# Clinical Assertion Engine (CAE) Testing Summary

## Overview

This document summarizes the results of testing the Clinical Assertion Engine (CAE) gRPC service with various test scripts developed to validate clinical reasoning functionality.

## Test Scripts Developed

1. **`test_cae_individual_functions.py`**
   - Tests individual CAE API functions
   - Fixed protobuf import issues
   - 6/7 tests passing (Learning Feedback test failing due to lack of assertions)

2. **`test_cae_specific_scenarios.py`**
   - Tests specific clinical scenarios using patient IDs from GraphDB
   - Focuses on drug interactions, therapeutic duplication, pediatric dosing, and contraindications
   - Uses patient data from `cae-sample-data.ttl`
   - All tests failing due to request format issues

3. **`test_cae_direct_scenarios.py`**
   - Tests scenarios with directly supplied medication and condition data
   - Bypasses GraphDB dependency
   - All tests failing due to request format issues

4. **`test_cae_improved_scenarios.py`**
   - Improved test script based on the working `test_cae_real_patient.py`
   - **2/3 tests passing**: Warfarin interactions and Pregnancy contraindications
   - NSAID duplication test still failing

## Key Findings

### What Works

1. **CAE Service Health**: The service is healthy and responds to health check requests
2. **Warfarin-Related Safety Alerts**: The CAE correctly detects and reports bleeding risks with warfarin
3. **Pregnancy Contraindications**: The CAE correctly identifies warfarin as teratogenic and contraindicated in pregnancy

### What Doesn't Work

1. **NSAID Therapeutic Duplication**: The CAE does not detect or alert on duplicate NSAID therapy (ibuprofen + naproxen)
2. **Learning Feedback**: The Learning Feedback functionality cannot be tested due to lack of assertions to provide feedback on

### Technical Lessons Learned

1. **Request Format Requirements**:
   - Using `medication_ids` and `condition_ids` directly is essential
   - Setting `priority` to `PRIORITY_URGENT` improves detection
   - Including `reasoner_types` is crucial (e.g., "interaction", "contraindication")
   - Adding `include_graphdb_data: true` in the patient context helps with data enrichment

2. **Response Handling**:
   - CAE returns assertions with various types including "unknown" and "absolute"
   - Assertions may not have a standardized "type" field for categorization
   - Content-based detection (checking description text) is more reliable than type-based detection

3. **Protobuf Integration**:
   - Relative imports in generated protobuf files cause issues
   - Dynamic module loading and patching resolves these issues

## Recommendations

1. **CAE Service Configuration**:
   - Confirm with CAE developers if NSAID therapeutic duplication detection is supported
   - Verify if specific medication identifiers need to be used for therapeutic class recognition

2. **Test Suite Improvements**:
   - Continue refining test scenarios based on known supported rules
   - Add more test cases covering additional clinical scenarios
   - Create integration tests that combine multiple clinical factors

3. **GraphDB Integration**:
   - Ensure GraphDB has complete medication class hierarchies for duplication detection
   - Verify proper linking between medications and their therapeutic classes

4. **Documentation**:
   - Document the expected request format for different clinical scenarios
   - Create a catalog of supported clinical rules and their requirements

## Conclusion

The Clinical Assertion Engine is functioning correctly for key safety scenarios including drug interactions and pregnancy contraindications. The testing infrastructure has been successfully established with proper protobuf integration. Further collaboration with the CAE development team is recommended to understand the full scope of supported clinical rules and to enhance test coverage.

## Next Steps

1. Review test results with clinical domain experts
2. Extend test coverage for additional clinical scenarios
3. Integrate tests into CI/CD pipeline for regression testing
4. Address any missing clinical rules through CAE configuration or development
